2024年7月12日，trinity biotech与Craig-Hallum资本集团签订ATM发行协议，根据协议，trinity biotech可以卖出价值550万美元的ADS股票，每个ADS股票代表公司20个A类普通股（trinity biotech还将支付Craig-Hallum一笔代理费）。
该协议可能通过多项或单项交易在纳斯达克上进行，或者其他任何可交易的场所或市场销售。此次发行的ADS股票将发行给投资者，价格将根据市场价格而定。
On July 12, 2024, Trinity Biotech Entered Into An ATM Offering Agreement With Craig-Hallum Capital Group, Pursuant To Which May Sell Up To $5.5M Of Its ADSs, Each ADS Representing 20 Of The Company's A Ordinary Shares (Co Will Also Pay Craig-Hallum A...
On July 12, 2024, Trinity Biotech Entered Into An ATM Offering Agreement With Craig-Hallum Capital Group, Pursuant To Which May Sell Up To $5.5M Of Its ADSs, Each ADS Representing 20 Of The Company's A Ordinary Shares (Co Will Also Pay Craig-Hallum A...
On July 12, 2024, Trinity Biotech Entered Into An ATM Offering Agreement With Craig-Hallum Capital Group, Pursuant To Which May Sell Up To $5.5M Of Its ADSs, Each ADS Representing 20 Of The Company's A Ordinary Shares (Co Will Also Pay Craig-Hallum A Commission Equal To 3% Of The Gross Sales Price Of ADSs)
2024年7月12日，Trinity Biotech与Craig-Hallum Capital Group签订ATM Offering协议，根据此协议可能出售多达550万美元的ADS，每个ADS代表公司20股A类普通股（公司还将向Craig-Hallum支付其ADS毛售价3%的佣金）。
On July 12, 2024, Trinity Biotech plc (the "Company") entered into an At the Market Offering Agreement (the "Sales Agreement") with Craig-Hallum Capital Group LLC ("Craig-Hallum"), pursuant to which the Company may sell up to $5,500,000 of its American Depositary Shares ("ADSs"), each ADS representing 20 of the Company's A Ordinary Shares, par value $0.0109 per share, from time to time, through Craig-Hallum, acting as sales agent.
2024年7月12日，Trinity Biotech plc（以下简称“公司”）与Craig-Hallum Capital Group LLC（以下简称“Craig-Hallum”）签订了“At the Market Offering Agreement（下称“Sales Agreement”）协议，根据此协议公司可能通过销售代理商Craig-Hallum，不时销售高达5,500,000美元的美国存托股票（以下简称“ADSs”），每个ADS代表公司20股普通A类股，每股面值0.0109美元。
Subject to the terms and conditions of the Sales Agreement, the Company will, from time to time, set the parameters for the sale of ADSs, including any price, time or size limits or other customary parameters or conditions, and Craig-Hallum will use its commercially reasonable efforts to sell the ADSs when requested by the Company. The Sales Agreement is filed herewith as Exhibit 1.1.
根据Sales Agreement的条款和条件，公司将不时确定ADS的销售参数，包括任何价格，时间或大小限制，或其他惯常参数或条件，Craig-Hallum会在公司要求时尽其商业合理努力出售ADS。Sales Agreement作为附件1.1提交。
In the Sales Agreement, the Company has agreed to provide Craig-Hallum with customary indemnification rights. The Company will also pay Craig-Hallum a commission equal to 3.0% of the gross sales price of ADSs sold pursuant to the Sales Agreement.
在Sales Agreement中，公司同意向Craig-Hallum提供惯常的赔偿权利。此外，公司还将向Craig-Hallum支付合同约定ADS毛售价3.0%的佣金。
Sales of the ADSs under the Sales Agreement may be made by any method permitted by law deemed to be an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended.
在Sales Agreement项下，ADS的销售可以采用任何法律允许的方法，被认为是1933年证券法修正案第415(a)(4)条规定的“现场发售”（at the market offering）。